Table 3 Logistic regression analysis of features for diagnosing HCC

Major features

 APHE

220 (88.0)

95 (54.0)

6.25 (3.86–10.14)

< 0.001

3.12 (1.71–5.70)

< 0.001

 Washout

193 (77.2)

31 (17.6)

14.73 (9.08–23.92)

< 0.001

10.74 (6.30-18.28)

< 0.001

 Enhancing capsule

117 (46.8)

17 (9.7)

8.23 (4.71–14.38)

< 0.001

7.13 (3.74–13.61)

< 0.001

 Threshold growth^a

32 (12.8)

22 (12.5)

1.03 (0.58–1.84)

0.927

Ancillary features

 Subthreshold growth^b

37 (14.8)

15 (8.5)

1.87 (0.99–3.51)

0.054

 Corona enhancement

17 (6.8)

12 (6.8)

0.99 (0.46–2.14)

0.994

 Fat sparing in solid mass

4 (1.6)

2 (1.1)

1.42 (0.26–7.81)

0.691

 Restricted diffusion

229 (91.6)

147 (83.5)

2.15 (1.18–3.91)

0.012

 Mild-moderate T2 hyperintensity

232 (92.8)

143 (8.1)

3.62 (1.90–6.89)

< 0.001

 Iron sparing in solid mass

0 (0)

0 (0)

-

-

 TP hypointensity

222 (88.8)

122 (69.3)

3.51 (2.11–5.83)

< 0.001

 HBP hypointensity

236 (94.4)

142 (80.7)

4.04 (2.10–7.78)

< 0.001

 No-nenhancing capsule

8 (3.2)

3 (1.7)

1.91 (0.50–7.29)

0.346

 Nodule-in-nodule

15 (6.0)

1 (0.5)

11.17 (1.46–85.36)

0.02

9.83 (1.22–79.27)

0.032

 Mosaic architecture

12 (4.8)

3 (1.7)

2.91 (0.81–10.46)

0.102

 Fat-in-mass, more than adjacent liver

19 (7.6)

5 (2.8)

2.81 (1.03–7.68)

0.044

 Blood products in mass

18 (7.2)

3 (1.7)

4.48(1.30-15.43)

0.018